Consun Pharma repurchases 115,000 shares; treasury stock climbs to 459,000

Bulletin Express05-28

Consun Pharmaceutical Group Limited executed an on-market share buyback on 28 May 2026, purchasing 115,000 ordinary shares at prices between HKD 13.88 and HKD 14.01, for a volume-weighted average of HKD 13.97 per share. The transaction totalled HKD 1.61 million.

Following the repurchase: • Issued shares outstanding (excluding treasury stock) fell 0.01 % to 841.09 million. • Treasury shares rose to 459,000, keeping total issued shares unchanged at 841.55 million.

Buy-backs were conducted under the mandate approved on 26 May 2026, which authorises repurchases of up to 84.12 million shares. The 115,000 shares bought to date represent 0.14 % of that limit.

No shares have been cancelled; the repurchased stock is held in treasury. Under Hong Kong Stock Exchange rules, Consun Pharma is subject to a moratorium on issuing, selling or transferring shares until 27 June 2026.

The company confirmed that the transactions complied with all applicable listing rules, regulatory requirements and the terms of its explanatory statement dated 28 April 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1130691759?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-28 22:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130691759","market":"hk","top_or_hot":-1,"title":"Consun Pharma repurchases 115,000 shares; treasury stock climbs to 459,000","media":"Bulletin Express","content":"<p>Consun Pharmaceutical Group Limited executed an on-market share buyback on 28 May 2026, purchasing 115,000 ordinary shares at prices between HKD 13.88 and HKD 14.01, for a volume-weighted average of HKD 13.97 per share. The transaction totalled HKD 1.61 million.</p>\n<p>Following the repurchase:\n• Issued shares outstanding (excluding treasury stock) fell 0.01 % to 841.09 million.  \n• Treasury shares rose to 459,000, keeping total issued shares unchanged at 841.55 million.</p>\n<p>Buy-backs were conducted under the mandate approved on 26 May 2026, which authorises repurchases of up to 84.12 million shares. The 115,000 shares bought to date represent 0.14 % of that limit.</p>\n<p>No shares have been cancelled; the repurchased stock is held in treasury. Under Hong Kong Stock Exchange rules, Consun Pharma is subject to a moratorium on issuing, selling or transferring shares until 27 June 2026.</p>\n<p>The company confirmed that the transactions complied with all applicable listing rules, regulatory requirements and the terms of its explanatory statement dated 28 April 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consun Pharma repurchases 115,000 shares; treasury stock climbs to 459,000</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsun Pharma repurchases 115,000 shares; treasury stock climbs to 459,000\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-28 22:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Consun Pharmaceutical Group Limited executed an on-market share buyback on 28 May 2026, purchasing 115,000 ordinary shares at prices between HKD 13.88 and HKD 14.01, for a volume-weighted average of HKD 13.97 per share. The transaction totalled HKD 1.61 million.</p>\n<p>Following the repurchase:\n• Issued shares outstanding (excluding treasury stock) fell 0.01 % to 841.09 million.  \n• Treasury shares rose to 459,000, keeping total issued shares unchanged at 841.55 million.</p>\n<p>Buy-backs were conducted under the mandate approved on 26 May 2026, which authorises repurchases of up to 84.12 million shares. The 115,000 shares bought to date represent 0.14 % of that limit.</p>\n<p>No shares have been cancelled; the repurchased stock is held in treasury. Under Hong Kong Stock Exchange rules, Consun Pharma is subject to a moratorium on issuing, selling or transferring shares until 27 June 2026.</p>\n<p>The company confirmed that the transactions complied with all applicable listing rules, regulatory requirements and the terms of its explanatory statement dated 28 April 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣药业","start_time":0,"source_url":"","article_id":"1130691759","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130691759","pubTimestamp":1779977036,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Consun Pharmaceutical Group Limited executed an on-market share buyback on 28 May 2026, purchasing 115,000 ordinary shares at prices between HKD 13.88 and HKD 14.01, for a volume-weighted average of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业回购11.5万股；库存股攀升至459,000股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"Consun Pharmaceutical Group Limited executed an on-market share buyback on 28 May 2026, purchasing 115,000 ordinary shares at prices between HKD 13.88 and HKD 14.01, for a volume-weighted average of HKD 13.97 per share. The transaction totalled HKD 1.61 million.\nFollowing the repurchase:\n• Issued shares outstanding (excluding treasury stock) fell 0.01 % to 841.09 million.  \n• Treasury shares rose to 459,000, keeping total issued shares unchanged at 841.55 million.\nBuy-backs were conducted under the mandate approved on 26 May 2026, which authorises repurchases of up to 84.12 million shares. The 115,000 shares bought to date represent 0.14 % of that limit.\nNo shares have been cancelled; the repurchased stock is held in treasury. Under Hong Kong Stock Exchange rules, Consun Pharma is subject to a moratorium on issuing, selling or transferring shares until 27 June 2026.\nThe company confirmed that the transactions complied with all applicable listing rules, regulatory requirements and the terms of its explanatory statement dated 28 April 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1130691759","isCrawlerRequest":true}